Home

Open Call HORIZON-HLTH-2023-IND-06-07: Development and Harmonisation of Methodologies for Assessing Digital Health Technologies in Europe

This topic aims at addressing digital transition challenges through supporting activities that are enabling or contributing to one or several expected impacts of destination 6 "Maintaining an innovative, sustainable and globally competitive health industry". More specifically, this topic aims at supporting activities that are contributing to the following impact area: "High quality digital services for all".

AI Aids Discovery of Super Tight-Binding Antibodies

Scientists at University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based strategy for discovering high-affinity antibody drugs.

In the study, published January 28, 2023 in Nature Communications, researchers used the approach to identify a new antibody that binds a major cancer target 17-fold tighter than an existing antibody drug.

DMEA 2023: Digital Health Live in Berlin

25 - 27 April 2023, Berlin, Germany.
From 25 to 27 April 2023 on the Berlin Exhibition Grounds, the focus will be on digitalisation in the healthcare sector, with topics ranging from digitalisation strategies for the healthcare sector and nursing, to consumer health and data protection in inpatient facilities as well as interoperability.

AI can Help Patients Interpret Home Tests for COVID-19

New machine learning research led by Professor Farrokh Alemi and Professor Janusz Wojtusiak provides a way for patients and clinicians to better predict whether symptoms are due to COVID-19, influenza, or RSV. A more accurate diagnosis leads to better decisions on course of care to heal patients and prevent the disease from spreading.

SAE Media Group Proudly Presents the 4th Annual AI in Drug Discovery Conference

13 - 14 March 2023, London, UK.
SAE Media Group is proud to present its 4th Annual AI in Drug Discovery Conference, taking place from 13 - 14 March 2023 in London, UK.

With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through the use of machine and deep learning.

AI Analysis of Cancer Mutations may Improve Therapy

Cancer has many faces - no wonder, then, that the range of cancer-causing mutations is huge as well. The totality of such genomic alterations in an individual is what experts call a "mutational landscape." These landscapes differ from one another depending on the type of cancer. And even people suffering from the same cancer often have different mutation patterns.

AI, Diabetes Experts Combine Forces for Blood Sugar Management Study

To help the estimated 1.45 million Americans living with type 1 diabetes better manage their blood sugar levels, Oregon Health & Science University is combining the power of an artificial intelligence-driven smartphone app with the support of human experts.

The Leona M. and Harry B. Helmsley Charitable Trust has awarded OHSU more than $4.3 million to support this work.

DIGITAL HEALTH NEWS

Open Call HORIZON-HLTH-2023-IND-06-07: Development and Harmonisation of Methodologies for Assessing Digital Health Technologies in Europe

AI Aids Discovery of Super Tight-Binding Antibodies

DMEA 2023: Digital Health Live in Berlin

AI can Help Patients Interpret Home Tests for COVID-19

SAE Media Group Proudly Presents the 4th Annual AI in Drug Discovery Conference

AI Analysis of Cancer Mutations may Improve Therapy

AI, Diabetes Experts Combine Forces for Blood Sugar Management Study

More eHealth News ...

Latest Business News

Latest Research News

Latest Conferences News

Latest Jobs